ReviewOncoTargets and therapy2022

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia.

Sara De Santis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.